• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for week of March 19, 2007

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDate and SiteOther FDA ParticipantsNon-FDA ParticipantsSubject
Dr. Jesse L. Goodman, MPH, Director, Center for Biologics Evaluation and Research3/6/07 Bethesda, MDN/ACommitte of Ten Thousand RepresentativesTo discuss general topics of interest
Robert Brackett, Director of CFSAN; Janice Oliver, Deputy Center Director for Operations3/6/07 Harvey Wiley Building, College Park, MDDavid Acheson, Director, OFDCER; Phil Spiller, OCD; Robert Wagner, OFDCER; Mike Bolger, OFS; Robyn Jones, EOS; Bill Jones, OFS; Don Kraemer, OFS; and Richard Williams, ORPSSErica Fleisig and Rita Schoeny, EPA/OW; Denise Kechner, EPA/OST; John Wathen and Bill Gross, EPA/OW/DST; Arnold Kuzmack, EPA; and Jeff Bigler, EPA/OWFDA-EPA MOU on Contaminants in Fish: 2007-Update
Dr. Jesse L. Goodman, MPH, Director, Center for Biologics Evaluation and Research3/8-10/07 Chandler, AZN/AAdvaMedAdvaMed Annual Meeting
Janice Oliver, Deputy Center Director for Operations3/13/07 Harvey Wiley Building, College Park, MDKaren Egan, Clarance Murray, Henry Kim, and Mike Bolger, OFS; Robyn Jones, EOSBeth Doyle, Phil Oshida, and David Hardy, EPAFDA-EPA regarding Perchlorate and Total Diet Study
Janet Woodcock, Deputy Commissioner and Chief Medical Officer3/13/07 Rockville, MDDr. Rachel BehrmanMara Aspinall and Allison Lawton, GenzymeMeet and Greet
Janet Woodcock, Deputy Commissioner and Chief Medical Officer3/15/07 Rockville, MDDr. Rachel Behrman, Dr. Paul Seligman, Ralph Lillie, and Melissa MoncavageAlice Till, Paul Stang, and Jean-Loui Saillot, PhRMATo discuss PhRMA initiative to develop a CME course on adverse event reporting
Andrew C. von Eschenbach, M.D., Commissioner of FDA3/15/07 Washington, DCSusan Winckler, Mike Landa, Sheldon Bradshaw, Randall Lutter, Bill Frankos, Nega Beru, Barbara Schneeman, Mary Poos, and Wanda RussNSF International: Kevin Lawlor, Lori Bestervelt, and Stan Hazan; Park and Associates Inc.: Douglas Park; and Sellery Asociates, Inc.: Amy KimballTo discuss advancing third-party programs to meet regulatory mandates.
Margaret Glavin, ACRA, ORA3/19/07Jesse Goodman, Deb Autor, Steven Galson, Tim Ulatowski, Daniel Schultz, Diana Kolaitis, David Horowitz, Joe Famulare, Steve Gutman and Mary MalarkeyJohn Landgraf, Joe Nemmers, Michael Beatrice, Cecilia Kimberline and Bob StewartUpdate FDA Executive Management on Abbott Laboratories
Murray M. Lumpkin, MD, Deputy Commissioner for International and Special Programs3/19/07 Basel, SwitzerlandNoneUniversity of Basel;ECMP Masters Level Program in Drug Development StudentsLecture and workshop regarding an introduction to drug and biologic regulation in the US and areas of convergence with EU systems
Steven Galson, Director, Center for Drug Evaluation and Research3/13/07 Washington, DCFDA Staff members and officicalsIndustrySpoke at CERTS PATHs (Partnerships to Advance Therapeutics) Meeting